Year in Review: 2018/2019 in numbers

Combined Pharmaceutical Budget 2018/2019

  • $985m – DHBs' combined pharmaceutical expenditure
  • 10 – number of medicines with widened access
  • 10 – number of new medicines funded
  • 47.2 million – number of funded prescription items
  • 3.77 million – number of New Zealanders receiving funded medicines (2.5 percent increase on previous year)
  • 75.4 million – amount of savings achieved to reinvest in medicines
  • 138,346 – estimated number of additional patients benefitting from new funded medicines

Hospital medical devices 2018/2019

  • 29,880 – additional line items added to the Pharmaceutical Schedule
  • $76m – value of medical devices secured under national contracts during 2018/2019
  • 106,628 – total line items on the Pharmaceutical Schedule under national contracts
  • $255m – total value of medical devices under PHARMAC contract

 

 < Chief Executives foreword | A cure for hepatitis C >